The GLP is committed to full transparency. Download and review our Annual Report.

Bayer nears end game in merger talks with Monsanto

, | | September 6, 2016

German pharmaceutical and crops manufacturer Bayer AG (BAYGn.DE) said on [September 5, 2016] that its negotiations with Monsanto Co (MON.N) had advanced, and it was now willing to offer more than $65 billion to acquire the world’s largest seed company.

Bayer in a statement said that it was prepared to offer $127.50 per share in connection with a negotiated deal, up from its previous offer of $125 per share.

ChemChina agreed earlier this year to buy Switzerland’s Syngenta (SYNN.S) for $43 billion, after the latter rejected takeover approaches from Monsanto. Dow Chemical Co (DOW.N) and DuPont (DD.N) are forging a $130 billion merger, which is to be followed by a break-up into three businesses.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Read full, original post: Bayer sweetens Monsanto bid as talks enter final stretch

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend